Literature DB >> 27066884

Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia.

Maryam Nazari1, Somaye Keshavarz2, Ali Rafati3, Mohammad Reza Namavar4, Masoud Haghani5.   

Abstract

Fingolimod (FTY720) is a known sphingosine-1-phosphate (S1P) receptor agonist. Several studies have shown the therapeutic efficacy of FTY720 in neurodegenerative disorders. However, the neuroprotective mechanisms in brain ischemia have not been adequately studied. Therefore, the present study aimed to investigate the effects of FTY720 on the impairment of learning and memory and hippocampal synaptic plasticity induced by middle cerebral artery occlusion (MCAO) in ischemic brain injury. Twenty eight male rats were randomly divided into four groups of control (n=7), sham (n=8), ischemic-reperfusion+vehicle (I/R+V; n=7), and I/R+FTY720 (n=6). After 1h of the occlusion of artery, the filament was gently withdrawn to allow reperfusion for the next 7 days. The animals first received a dose of FTY720 (0.5mg/Kg) or its vehicle (intra-peritoneal) twenty-four hours before surgery in I/R+FTY720 and I/R+V groups, respectively. The administration of FTY720 or its vehicle continued every other day. The passive avoidance test and field potential recording were used for evaluation of learning, memory and synaptic plasticity. The brain infarct volume was measured by triphenyltetrazolim hydrochloride (TTC) staining. MCAO caused infarct damage in the rat's brain tissue. The administration of FTY720 significantly reduced the size of the lesion, improved the memory impairment of MCAO rats, and increased the STL time. In addition, the field potential recording demonstrated a marked reduction in induction of long-term potentiation of MCAO animals. However, administration of FTY720 recovers the magnitude of the LTP without any effects on presynaptic plasticity and neurotransmitter release probability. The results of this study demonstrated that MCAO in rats impairs the retention of passive avoidance tasks and multiple injection of FTY720 improved the memory performance after MCAO by LTP induction via post-synaptic mechanisms.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FTY720; Fingolimod; LTP; Sphingosine-1-phosphate; Stroke

Mesh:

Substances:

Year:  2016        PMID: 27066884     DOI: 10.1016/j.brainresbull.2016.04.004

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  29 in total

1.  Precision Stroke Animal Models: the Permanent MCAO Model Should Be the Primary Model, Not Transient MCAO.

Authors:  Devin W McBride; John H Zhang
Journal:  Transl Stroke Res       Date:  2017-07-17       Impact factor: 6.829

2.  Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia.

Authors:  Bhakta Prasad Gaire; Chi-Ho Lee; Arjun Sapkota; Sang Yeul Lee; Jerold Chun; Hee Jun Cho; Tae-Gyu Nam; Ji Woong Choi
Journal:  Mol Neurobiol       Date:  2017-03-25       Impact factor: 5.590

3.  Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation.

Authors:  Veit Rothhammer; Jessica E Kenison; Emily Tjon; Maisa C Takenaka; Kalil Alves de Lima; Davis M Borucki; Chun-Cheih Chao; Annabel Wilz; Manon Blain; Luke Healy; Jack Antel; Francisco J Quintana
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

Review 4.  Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.

Authors:  Efthalia Angelopoulou; Christina Piperi
Journal:  Neuromolecular Med       Date:  2019-07-16       Impact factor: 3.843

5.  Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury.

Authors:  Tengfei Xue; Juan Ji; Yuqin Sun; Xinxin Huang; Zhenyu Cai; Jin Yang; Wei Guo; Ruobing Guo; Hong Cheng; Xiulan Sun
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

6.  Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.

Authors:  Bhakta Prasad Gaire; Ji Woong Choi
Journal:  Neuromolecular Med       Date:  2020-09-10       Impact factor: 3.843

7.  Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod.

Authors:  Henryk Jęśko; Iga Wieczorek; Przemysław Leonard Wencel; Magdalena Gąssowska-Dobrowolska; Walter J Lukiw; Robert Piotr Strosznajder
Journal:  Front Mol Neurosci       Date:  2021-07-09       Impact factor: 5.639

Review 8.  The S1P-S1PR Axis in Neurological Disorders-Insights into Current and Future Therapeutic Perspectives.

Authors:  Alexandra Lucaciu; Robert Brunkhorst; Josef M Pfeilschifter; Waltraud Pfeilschifter; Julien Subburayalu
Journal:  Cells       Date:  2020-06-22       Impact factor: 6.600

9.  Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke.

Authors:  Wentao Li; Haoliang Xu; Fernando D Testai
Journal:  Front Neurol       Date:  2016-08-26       Impact factor: 4.003

Review 10.  Immunotherapy of experimental and human stroke with agents approved for multiple sclerosis: a systematic review.

Authors:  Mirjam Dreikorn; Zeljko Milacic; Vladimir Pavlovic; Sven G Meuth; Christoph Kleinschnitz; Peter Kraft
Journal:  Ther Adv Neurol Disord       Date:  2018-04-20       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.